Assertio Holdings (ASRT) EBT Margin (2019 - 2026)
Assertio Holdings' (ASRT) quarterly EBT Margin came in at 189.38% in Q1 2026, down 13918.0% year-on-year from N/an in Q1 2025, and down 118.34% quarter-over-quarter from 86.74% in Q4 2025.
Assertio Holdings (ASRT) EBT Margin (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed EBT Margin across 8 years of filings, most recently posting 189.38% for Q1 2026.
- EBT Margin for Q1 2026 came in at 189.38%, down 13918.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 34.71% (down 912.0% YoY), and the FY2025 annual result was 25.22%, down 799.0% from the prior year.
- EBT Margin came in at 189.38% for Q1 2026 at Assertio Holdings, down from 86.74% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 30.08% in Q2 2023 to a low of 642.45% in Q3 2023.
- The 5-year median for EBT Margin is 13.17% (2023), against an average of 62.87%.
- Across the five-year window, EBT Margin slumped 65526 bps in 2023 and soared 63260 bps in 2024, its largest moves.
- Assertio Holdings' EBT Margin stood at 17.04% in 2022, then plunged by 668 bps to 96.73% in 2023, then surged by 65 bps to 33.4% in 2024, then plunged by 160 bps to 86.74% in 2025, then plunged by 118 bps to 189.38% in 2026.
- The last three EBT Margin figures came in at 189.38% (Q1 2026), 86.74% (Q4 2025), and 23.05% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | -189.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -189.38% |
| Dec 31, 2025 | -86.74% |
| Sep 30, 2025 | 23.05% |
| Jun 30, 2025 | -55.77% |
| Mar 31, 2025 | -50.20% |
| Dec 31, 2024 | -33.40% |
| Sep 30, 2024 | -9.85% |
| Jun 30, 2024 | -11.32% |
| Mar 31, 2024 | -13.49% |
| Dec 31, 2023 | -96.73% |
| Sep 30, 2023 | -642.45% |
| Jun 30, 2023 | 30.08% |
| Mar 31, 2023 | -13.17% |
| Dec 31, 2022 | 17.04% |
| Sep 30, 2022 | 12.81% |
| Jun 30, 2022 | 23.99% |
| Mar 31, 2022 | 26.76% |
| Dec 31, 2021 | 15.12% |
| Sep 30, 2021 | 14.85% |
| Jun 30, 2021 | -57.03% |